TrialEndocrine2014

Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial.

Wen-Hao Tang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.